CardioCel® is approved/cleared for sale in Europe, the US, Canada, Hong Kong, Malaysia, Singapore, New Zealand and Middle East and North Africa Region. CardioCel® is also available under the special access scheme in Australia and other select countries.

CardioCel® is currently used by leading heart centres around the world and has been implanted in thousands of patients to date.